Literature DB >> 32588930

Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV-negative head and neck squamous cell carcinoma patients.

Xavier León1,2, Eduard Neumann1, Alfons Gutiérrez1, Jacinto García1, Montserrat López1, Miquel Quer1,2.   

Abstract

BACKGOUND: The objective of this study is to assess a new parameter, the weighted lymph node ratio (WLNR), which incorporates prognostic information regarding the number of metastatic nodes with extracapsular spread and the lymph node yield for pN0 patients to the lymph node ratio.
METHODS: We studied retrospectively 1118 patients with head and neck squamous cell carcinoma (HNSCC) treated with a neck dissection.
RESULTS: We obtained a classification with four categories based on the WLNR values. WLNR classification had a higher prognostic discrimination capacity and a more homogeneous distribution in the number of patients included in each of the categories than the pTNM classification.
CONCLUSION: The WLNR improved the predictive capacity of the eighth edition of the pTNM classification and it can be a useful tool in the assessment of the postoperative staging of the neck dissections in HNSCC patients.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  TNM classification; extracapsular spread; lymph node ratio; lymph node yield; pN

Mesh:

Year:  2020        PMID: 32588930     DOI: 10.1002/hed.26340

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Prognostic capacity of the weighted lymph node ratio in head and neck squamous cell carcinoma patients treated with salvage neck dissection.

Authors:  Eduard David Neumann; Aina Sansa; María Casasayas; Alfons Gutierrez; Miquel Quer; Xavier León
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-16       Impact factor: 2.503

2.  Radiomic Model Predicts Lymph Node Response to Induction Chemotherapy in Locally Advanced Head and Neck Cancer.

Authors:  Michael H Zhang; David Cao; Daniel T Ginat
Journal:  Diagnostics (Basel)       Date:  2021-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.